Product: Cefditoren Pivoxil Tablets

Manufacturer: Meiji Seika Pharma Co., Ltd., Japan

Specification: 100mg*10 tablets/box

Indications:

For infections caused by bacteria sensitive to this agent, including Staphylococcus, Streptococcus, Enterococcus, Actinobacillus catarrhalis, Propionibacterium acnes, Escherichia coli, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus (Proteus mirabilis, Proteus vulgaris), Morganella, Providencia, Haemophilus influenzae, and Bacteroides:

1. Oral infections: periodontitis, pericoronitis, osteomyelitis;

2. Respiratory system infections: acute bronchitis, chronic bronchitis, bronchiectasis (when infected), secondary infection of chronic respiratory diseases, pneumonia, pulmonary abscess;

3. ENT system infections: pharyngitis (pharyngeal abscess), tonsillitis (peritonsillar inflammation, peritonsillar abscess), otitis media, sinusitis;

4. Urinary system infections: cystitis, pyelonephritis;

5. Skin infections: folliculitis, boils, furunculosis, carbuncles, impetigo contagiosa, erysipelas, cellulitis, lymphangitis/lymphadenitis, purulent paronychia, scrofula, subcutaneous abscess, hidradenitis, infected sebaceous cyst, chronic pyoderma;

6. Ophthalmic infections: blepharitis, stye, eyelid abscess, meibomian gland inflammation, dacryocystitis;

7. Gynecological system infections: adnexitis, intrauterine infection, vestibular gland infection;

8. Digestive system infections: cholecystitis, cholangitis;

9. Surgical infections: mastitis, perianal abscess, superficial secondary infections of trauma and surgical wounds.

Product Advantages:

• A third-generation cephalosporin antibiotic that provides balanced coverage against major oral pathogens (anaerobic and aerobic bacteria);

• Specifically indicated in the package insert for oral infections with a defined antibacterial spectrum;

• No contraindications for breastfeeding women; minimal distribution in breast milk among oral third-generation cephalosporins;

• Higher safety in oral infection treatment (adverse reaction rate only 0.71%) and lower resistance rate (resistance rate less than 0.4%) among third-generation cephalosporins;

• Rapid onset of action, effective within 2 hours;

• Original imported product, thoroughly clinically tested in both Japan and China, ensuring effectiveness and safety.